ABBV vs. NGD
ABBV (AbbVie Inc.) and NGD (New Gold Inc.) are both stocks. ABBV operates in Drug Manufacturers - General (Healthcare), while NGD operates in Gold (Basic Materials). At a 0.03 correlation, their price movements are largely independent.
Performance
ABBV vs. NGD - Performance Comparison
Loading charts...
Returns By Period
ABBV
- 1D
- 1.32%
- 1M
- 8.05%
- YTD
- 1.30%
- 6M
- 3.65%
- 1Y
- 23.06%
- 3Y*
- 22.39%
- 5Y*
- 18.94%
- 10Y*
- 19.10%
NGD
- 1D
- —
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ABBV vs. NGD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 1.30% | 33.08% | 18.86% | -0.23% | 24.01% | 32.43% | 27.72% | 1.47% | -0.96% | 60.07% |
NGD New Gold Inc. | 4.25% | 251.21% | 69.86% | 48.98% | -34.67% | -31.51% | 148.86% | 16.28% | -77.00% | -6.00% |
Correlation
The correlation between ABBV and NGD is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.07 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.02 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.06 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.04 |
Correlation (All Time) Calculated using the full available price history since Jan 2, 2013 | 0.03 |
Fundamentals
ABBV:
$2.05
NGD:
$1.61
ABBV:
110.96
NGD:
5.64
ABBV:
6.43
NGD:
3.30
ABBV:
$62.82B
NGD:
$1.46B
ABBV:
$46.15B
NGD:
$758.26M
ABBV:
$17.96B
NGD:
$1.19B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ABBV vs. NGD — Risk / Return Rank
ABBV
NGD
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
ABBV vs. NGD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AbbVie Inc. (ABBV) and New Gold Inc. (NGD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ABBV | NGD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.18 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 1.29 | — | — |
| Martin ratioReturn relative to average drawdown | 2.88 | — | — |
Loading charts...
Drawdowns
ABBV vs. NGD - Drawdown Comparison
Loading charts...
Drawdown Indicators
| ABBV | NGD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -45.09% | — | — |
Max Drawdown (1Y)Largest decline over 1 year | -17.32% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -20.74% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -21.92% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -45.09% | — | — |
Current DrawdownCurrent decline from peak | -4.60% | — | — |
Average DrawdownAverage peak-to-trough decline | -10.71% | — | — |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.75% | — | — |
Volatility
ABBV vs. NGD - Volatility Comparison
Loading charts...
Volatility by Period
| ABBV | NGD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.10% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 17.85% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 24.31% | — | — |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.89% | — | — |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.73% | — | — |
Dividends
ABBV vs. NGD - Dividend Comparison
ABBV's dividend yield for the trailing twelve months is around 2.96%, while NGD has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 2.96% | 2.87% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% |
NGD New Gold Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
ABBV vs. NGD - Financials Comparison
This section allows you to compare key financial metrics between AbbVie Inc. and New Gold Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ABBV and NGD have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for ABBV and NGD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer